Skip to Content
Merck
CN

L3276

Monoclonal Anti-LEF-1 antibody produced in mouse

~1 mg/mL, clone 1C3, purified immunoglobulin

Synonym(s):

Anti-Lymphoid Enhancer Factor-1

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
MDL number:
Conjugate:
unconjugated
Clone:
1C3, monoclonal
Application:
WB
Citations:
1
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

Quality Level

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

1C3, monoclonal

mol wt

antigen 55-57 kDa

species reactivity

human

concentration

~1 mg/mL

technique(s)

western blot: 1-5 μg/mL using whole extracts of human Jurkat cells or transiently expressed human LEF-1 in whole cell lysates from Cos-1 cells

isotype

IgG1

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... LEF1(51176)

Looking for similar products? Visit Product Comparison Guide

Immunogen

recombinant full length LEF-1.

Physical form

Solution in 0.01 M phosphate buffered saline containing 0.08% sodium azide.

Preparation Note

Purified from cell culture supernatnant.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

Regulatory Information

新产品

This item has


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Pedro L Azevedo et al.
Translational oncology, 12(4), 614-625 (2019-02-01)
Mesenchymal stromal cells (hMSCs) are key components of the bone marrow microenvironment (BMM). A molecular signature in hMSCs from Acute myeloid leukemia patients (hMSC-AML) has been proposed where BMP4 is decreased and could be regulated by WNT signaling pathway. Therefore

Related Content

Global Trade Item Number

SKUGTIN
L3276-.1MG04061836275884

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service